Why this ASX 200 stock is being tipped to rocket 100%

Motley Fool Australia on MSN

Analysts Offer Insights on Healthcare Companies: Neuren Pharmaceuticals Limited (OtherNURPF), Mesoblast Limited (OtherMEOBF) and Ramsay Health Care (OtherRMSYF)

The Globe and Mail

ASX 200 Edges Higher, Closing Out Above 9,200 as Energy Sector Jumps

The Bull

2 ASX 200 shares tipped to more than double in value

Motley Fool Australia on MSN

Interview with the CEO and Managing Director: Mesoblast Limited (NASDAQ:MESO)

The Wall Street Transcript

Inside Biotech: Big-cap healthcare results split the market

Proactive Investors

S&P/ASX 200 edges up as Australian shares end flat, energy, gold miners offset bank losses on Middle East conflict; check top gainers and losers

The Economic Times

Global stock sell-off hits ASX, trade halted in Korea as market plunges — as it happened

ABC (Australian Broadcasting Corporation)

Following Imre exit, Anna Kotis joins Calcium+Company as chief of advertising

Medical Marketing & Media

Evening Wrap: ASX 200 rebounds as bargain hunters lift tech stocks, Wisetech jumps 7%, Life360 up 6%

Market Index on MSN